The Monoclonal Antibody Congress 2014 Europe covers topics such as:
- Recent advances in antibody technology
- Insight on various therapeutic targets
- New antibody engineering and modification technologies
- What is the future in antibody technology
- New techniques in cell engineering for Mabs production
- Date platform approaches to monoclonal antibody purification
- Trends in capacity utilization for therapeutic mabs production
- Antibody-based targeted therapy
- Regulations, technologies, production and therapeutics
- Immunogenicity issues with drug development
The Monoclonal Antibody Congress 2014 Europe brings together Directors, VPs, Managers and Heads of:
- Preclinical research development
- Antibody Development
- Cell and Molecular Biology
- Clinical Research development
- Auto-immune Disorders
- Recombitant DNA Biotechnology
- Contract research Organizations
- Pharmaceutical and Patent Law
- New product development
- Clinical Diagnostics
- Business Development
- Oncology R&D
- Marketing
